Manorama Industries Limited approved an increase in share capital of up to ₹10 crore for each of its three wholly owned subsidiaries in West Africa. The board meeting held on September 22, 2026, authorized these infusions to support working capital requirements and general corporate purposes for entities in Benin, Togo, and Ivory Coast.

The decision aims to strengthen the company's international operations and market presence in the region. The funds will be deployed through cash subscriptions to the increased share capital of the subsidiaries. This move aligns with the company's existing business activities in trading and related sectors.

Subsidiary Details and Capital Allocation

The board approved the capital increase for three specific entities, all incorporated in late 2024 with initial capital of CFA 20 lakh. The allocation is structured as follows:

Manorama Africa Benin recorded a turnover of approximately ₹6.23 crore during FY26. The other two subsidiaries, Manorama Savanna Togo Sarl and Manorama Africa Savanna, did not record any significant turnover during FY25 or FY26.

Transaction Structure and Compliance

The transactions are classified as related party transactions since the subsidiaries are wholly owned by Manorama Industries. The company stated that the promoter group has no direct interest in these entities beyond their shareholding in the parent company. All transactions are being undertaken on an arm's length basis.

The company intends to complete the transactions in a calibrated and phased manner. This approach ensures efficient capital deployment aligned with business milestones and actual funding needs. The process remains subject to applicable regulatory and statutory approvals in the respective jurisdictions.

What the Numbers Show

The data reveals a strategic divergence in capital deployment across the African footprint. While all three subsidiaries receive identical maximum authorizations of ₹10 crore, only Manorama Africa Benin demonstrates immediate revenue traction with a turnover of ₹6.23 crore. The other two entities, incorporated in September and October 2024 respectively, remain pre-revenue. This suggests that while the parent company is standardizing its financial backing across the region, operational maturity varies significantly, with Benin serving as the current primary revenue generator among the new ventures.

Manorama Industries has completed the dispatch of its postal ballot notice seeking shareholder approval to appoint Dr. Rohini Tiwari as a non-executive independent director. The company confirmed the completion of dispatch on September 18, 2026, via advertisements in Business Standard and Loksatta.

The Board of Directors initially approved the appointment on September 4, 2026, following recommendations from the Nomination and Remuneration Committee. Dr. Tiwari was appointed as an additional director on that date pursuant to Section 161 of the Companies Act, 2013. The proposed term spans five consecutive years, commencing on September 4, 2026, and ending on September 3, 2031.

Voting Process

Shareholders holding equity shares as of the cut-off date of September 11, 2026, are eligible to vote via remote e-voting only. No physical ballot forms are being dispatched in compliance with Ministry of Corporate Affairs circulars. The voting window opens at 9:00 am on Saturday, September 19, 2026, and closes at 5:00 pm on Sunday, October 18, 2026.

The company has engaged MUFG Intime India Private Limited to facilitate the electronic voting process. Members holding shares in physical form without registered email IDs must register their details with the Registrar & Share Transfer Agent or the Company to enable voting. Those holding shares in dematerialized mode should update their email IDs with their Depository Participants.

M/s. Mehta & Mehta has been appointed as the scrutinizer to oversee the postal ballot process. Ms. Alifya Sapatwala will represent the firm, with Ms. Namrata Tatiya serving as alternate representative. Once cast, votes cannot be changed or recast. If approved, the resolution will be deemed passed on the last day of e-voting.

Director Profile

Dr. Rohini Tiwari brings multidisciplinary experience in food technology, nutrition, and quality assurance. She holds a Ph.D. in Food Science and Nutrition and has served as Chief Clinical Nutritionist at Ganga Hospital, Coimbatore. Her industry background includes quality assurance roles at Hindustan Coca-Cola Beverages Pvt. Ltd. and nutraceutical R&D consultancy with Dr. Reddy's Laboratories.

The appointment is subject to member approval via special resolution. The results will be declared within two working days from the closure of e-voting, expected by October 20, 2026.